Cellectar Biosciences Inc (CLRB)
3.30
-0.02
(-0.75%)
USD |
NASDAQ |
Apr 16, 16:00
3.30
0.00 (0.00%)
After-Hours: 17:01
Cellectar Biosciences Total Assets (Quarterly): 12.08M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.08M |
| September 30, 2023 | 21.55M |
| June 30, 2023 | 6.509M |
| March 31, 2023 | 14.84M |
| December 31, 2022 | 21.59M |
| September 30, 2022 | 19.32M |
| June 30, 2022 | 25.89M |
| March 31, 2022 | 31.99M |
| December 31, 2021 | 37.20M |
| September 30, 2021 | 41.95M |
| June 30, 2021 | 47.74M |
| March 31, 2021 | 55.06M |
| December 31, 2020 | 58.66M |
| September 30, 2020 | 20.70M |
| June 30, 2020 | 23.85M |
| March 31, 2020 | 8.690M |
| December 31, 2019 | 12.25M |
| September 30, 2019 | 15.66M |
| June 30, 2019 | 19.14M |
| March 31, 2019 | 12.55M |
| December 31, 2018 | 15.05M |
| September 30, 2018 | 19.54M |
| June 30, 2018 | 6.997M |
| March 31, 2018 | 9.561M |
| December 31, 2017 | 12.87M |
| Date | Value |
|---|---|
| September 30, 2017 | 9.871M |
| June 30, 2017 | 12.60M |
| March 31, 2017 | 15.30M |
| December 31, 2016 | 15.32M |
| September 30, 2016 | 9.296M |
| June 30, 2016 | 11.38M |
| March 31, 2016 | 5.570M |
| December 31, 2015 | 7.596M |
| September 30, 2015 | 6.462M |
| June 30, 2015 | 8.580M |
| March 31, 2015 | 10.91M |
| December 31, 2014 | 13.42M |
| September 30, 2014 | 15.72M |
| June 30, 2014 | 5.889M |
| March 31, 2014 | 8.040M |
| December 31, 2013 | 6.816M |
| September 30, 2013 | 9.647M |
| June 30, 2013 | 12.12M |
| March 31, 2013 | 14.31M |
| December 31, 2012 | 11.48M |
| September 30, 2012 | 10.39M |
| June 30, 2012 | 11.85M |
| March 31, 2012 | 8.648M |
| December 31, 2011 | 10.56M |
| September 30, 2011 | 6.995M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.509M
Minimum
Jun 2023
58.66M
Maximum
Dec 2020
26.04M
Average
21.55M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 97.89M |
| Eli Lilly and Co | 64.01B |
| Actinium Pharmaceuticals Inc | 81.44M |
| Bristol-Myers Squibb Co | 95.16B |
| Altimmune Inc | 210.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.43M |
| Shareholders Equity (Quarterly) | -1.356M |